Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China
· Delayed Price · Currency is CNY 10.99
+0.01 (0.09%)
Apr 30, 2026, 3:00 PM CST
SHA:603998 Revenue
Hunan Fangsheng Pharmaceutical had revenue of 462.77M CNY in the quarter ending March 31, 2026, with 10.69% growth. This brings the company's revenue in the last twelve months to 1.79B, up 1.93% year-over-year. In the year 2025, Hunan Fangsheng Pharmaceutical had annual revenue of 1.75B, down -1.75%.
Revenue (ttm)
1.79B
Revenue Growth
+1.93%
P/S Ratio
2.69
Revenue / Employee
991.22K
Employees
1,807
Market Cap
4.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.75B | -31.05M | -1.75% |
| Dec 31, 2024 | 1.78B | 148.95M | 9.15% |
| Dec 31, 2023 | 1.63B | -163.46M | -9.12% |
| Dec 31, 2022 | 1.79B | 225.03M | 14.36% |
| Dec 31, 2021 | 1.57B | 288.21M | 22.54% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yabao Pharmaceutical Group | 2.20B |
| Hubei Biocause Heilen Pharmaceutical | 459.02M |
| Jianmin Pharmaceutical Group | 3.35B |
| Fuan Pharmaceutical (Group) | 1.68B |
| Zhejiang Yatai Pharmaceutical | 318.16M |
| Shandong Sinobioway Biomedicine | 274.81M |
| Teyi Pharmaceutical Group Co.,Ltd | 924.53M |
| Zhejiang Sunflower Great Health | 253.87M |